218 related articles for article (PubMed ID: 11921430)
21. The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer.
Tamada JA; Davis TL; Leptien AD; Lee J; Wang B; Lopatin M; Wei C; Wilson D; Comyns K; Eastman RC
Diabetes Technol Ther; 2004 Jun; 6(3):357-67. PubMed ID: 15198839
[TBL] [Abstract][Full Text] [Related]
22. The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study.
Diabetes Research in Children Network (DIRECNET) Study Group
Diabetes Technol Ther; 2003; 5(5):791-800. PubMed ID: 14633344
[TBL] [Abstract][Full Text] [Related]
23. [Blood glucose monitoring by inverse iontophoresis].
Potts RO
Journ Annu Diabetol Hotel Dieu; 2000; ():67-74. PubMed ID: 10932869
[No Abstract] [Full Text] [Related]
24. Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance.
Kubiak T; Wörle B; Kuhr B; Nied I; Gläsner G; Hermanns N; Kulzer B; Haak T
Diabetes Technol Ther; 2006 Oct; 8(5):570-5. PubMed ID: 17037971
[TBL] [Abstract][Full Text] [Related]
25. Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies.
Laffel L
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S223-33. PubMed ID: 26784126
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin.
Chuang H; Taylor E; Davison TW
Diabetes Technol Ther; 2004 Feb; 6(1):21-30. PubMed ID: 15000766
[TBL] [Abstract][Full Text] [Related]
27. Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor.
Jina A; Tierney MJ; Tamada JA; McGill S; Desai S; Chua B; Chang A; Christiansen M
J Diabetes Sci Technol; 2014 May; 8(3):483-7. PubMed ID: 24876610
[TBL] [Abstract][Full Text] [Related]
28. In vivo glucose monitoring: the clinical reality and the promise.
Pickup JC; Hussain F; Evans ND; Sachedina N
Biosens Bioelectron; 2005 Apr; 20(10):1897-902. PubMed ID: 15741056
[TBL] [Abstract][Full Text] [Related]
29. Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes.
Zueger T; Diem P; Mougiakakou S; Stettler C
Diabetes Technol Ther; 2012 Jul; 14(7):583-8. PubMed ID: 22512266
[TBL] [Abstract][Full Text] [Related]
30. Glucose monitoring by reverse iontophoresis.
Pishko MV
Diabetes Technol Ther; 2000; 2(2):209-10. PubMed ID: 11469260
[No Abstract] [Full Text] [Related]
31. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.
Mastrototaro J; Shin J; Marcus A; Sulur G;
Diabetes Technol Ther; 2008 Oct; 10(5):385-90. PubMed ID: 18715215
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
Wadwa RP; Laffel LM; Shah VN; Garg SK
Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
[TBL] [Abstract][Full Text] [Related]
33. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study.
Hoss U; Jeddi I; Schulz M; Budiman E; Bhogal C; McGarraugh G
Diabetes Technol Ther; 2010 Aug; 12(8):591-7. PubMed ID: 20615099
[TBL] [Abstract][Full Text] [Related]
34. A sweeter life for diabetics?
Guy RH
Nat Med; 1995 Nov; 1(11):1132-3. PubMed ID: 7584978
[No Abstract] [Full Text] [Related]
35. Clinical experience of an iontophoresis based glucose measuring system.
Rhee SY; Chon S; Koh G; Paeng JR; Oh S; Woo JT; Kim SW; Kim JW; Kim YS
J Korean Med Sci; 2007 Feb; 22(1):70-3. PubMed ID: 17297254
[TBL] [Abstract][Full Text] [Related]
36. [Non-invasive self-monitoring of glycemia in the therapy of diabetes mellitus: hope or reality?].
Brunetti P
Recenti Prog Med; 2000 Nov; 91(11):552-8. PubMed ID: 11125946
[No Abstract] [Full Text] [Related]
37. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction.
Tamada JA; Bohannon NJ; Potts RO
Nat Med; 1995 Nov; 1(11):1198-201. PubMed ID: 7584995
[TBL] [Abstract][Full Text] [Related]
38. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.
Guerci B; Floriot M; Böhme P; Durain D; Benichou M; Jellimann S; Drouin P
Diabetes Care; 2003 Mar; 26(3):582-9. PubMed ID: 12610005
[TBL] [Abstract][Full Text] [Related]
39. Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept.
Sieg A; Guy RH; Delgado-Charro MB
J Pharm Sci; 2003 Nov; 92(11):2295-302. PubMed ID: 14603514
[TBL] [Abstract][Full Text] [Related]
40. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.
Bailey T; Zisser H; Chang A
Diabetes Technol Ther; 2009 Dec; 11(12):749-55. PubMed ID: 20001675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
